PLRX Stock Price
Pliant Therapeutics, Inc.
PLRX stock price is $0.88 (-8.69% on the day), giving Pliant Therapeutics, Inc. a market cap of $54.73M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
PLRX Stock Overview
- Price
- $0.88
- Previous close
- $0.97
- Open
- $0.96
- Market cap
- $54.73M
- P/E ratio
- -0.4
- 52-week range
- $0.97 - $1.95
- 1-year price target
- $2.50
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 33
About Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PLRX | $0.88 | -8.7% | 988.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Pliant Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW